Geriatrik Hastalarda Nöroonkolojik Sorunlar

Nilgün Şenol; Hakan Murat Göksel

doi:10.17343/sdutfd.358631

Geriatrik Hastalarda Nöroonkolojik Sorunlar

Öz

Dünya popülasyonu giderek yaşlanmakta ve bununla orantılı olarak bu yaş grubunda görülen hastalıkların insidans ve prevalansı artmaktadır. Özellikle bu yaş grubunda görülen nöroonkolojik hastalıklar kanser metastazları ve glioblastome multiformedir. Eşlik eden başka hastalıkların olması, kullanılan ilaçların yan etkileri ve uygulananan tedavi yöntemlerine bağlı gelişebilen komplikasyonlar, bu grup hastalarda tedavi planlamasını zorlaştırmakta, morbidite/mortalite oranlarının artmasına neden olmaktadır. Hastalarda yaşam kalitesini ve fonksiyonel bütünlüğü bozmadan en uygun tedavinin seçilebilmesi için önceden var olan ve sonradan eklenebilecek sorunların multidisipliner olarak değerlendirilmesi önemlidir.

Anahtar Kelimeler

nöroonkoloji

Kaynakça

1. Aboderin IA, Beard JR. Older people’s health in sub-Saharan Africa. Lancet. 2015; Feb 14;385(9968):e9-11
2. (http://www.tuik.gov.tr;08.07.2010) Saglik Bakanligi 2010 yili istatistikleri- Saglik Bakanligi Yayinlari, 2010;Ankara
3. Morioka T, Miyazaki H, Tsuruta K. Problems in neurosurgical operations on elderly patients-from the viewpoint of Anesthesiology. Neurol Med Chir (Tokyo) 1980;20:713-720
4. Delafuente JC. The silver tsunami is coming: Will pharmacy be swept away with the tide? Am J Pharm Educ 2009;73:1
5. Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancer and chemotherapy related cognitive dysfunction:current status. Semin Oncol 2011;38(3):431-438
6. Loh D, Hogg F, Edwards P, MacColl J,Brogna C,Bhangoo R. Two year experience of multi-disciplinary team (MDT) outcomes for brain metastases in a tertiary neuro-oncology centre. British J of Neurosurgery, 2017;https://doi.org/10.1080/02688697.2017.1368449
7. Weller M, Platten M, Roth P, Wick W. Geriatric neuro-oncology: from mythology to biology. Neurology 2011;24:599-604
8. Dolecek TA, Propp JM, Stroup NE, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncol. 2012;14(5):v1-v49

9. Pruitt AA. Medical management of patients with brain tumors. Curr Treat Options Neurol 2011;13:413-426
10. Chargari C, Feuvret L, Bauduceau O, et al. Treatment of elderly patients with glioblastoma: From clinical evidence to molecular highlights. Cancer Treat Rev. 2012;38(8):988-995
11. Batchelor TT, Betensky RA, Esposito JM, et al. Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res. 2004;10(1 Pt 1):228-233
12. McDonald KL, McDonnell J, Muntoni A, et al. Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. J Neuropathol Exp Neurol. 2010;69(7):729-736
13. Ohgaki H, Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res. 2013;19(4):764-772
14. Bauchet L, Zouaoui S, Darlix A, Champfleur NM, Ferreira E, Fabbro M, Kerr C, Taillandier L. Assessment and treatment relevance in elderly glioblastoma patients. Neuro-Oncology 2014;16(11):1459-1468
15. Hegi ME, Diserens A-C, Gorlia T, et al. MGMT Gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352(10):997-1003
16. Perez-Larraya JG, Delattre JY. Management of elderly patients with gliomas. The Oncologist 2014;19:1258-1267
17. Drappatz J, Schiff D, Kesari S, et al. Medical management of brain tumor patients. Neurol Clin 2007;25:1035-1071
18. Arif H, Buchsbaum R, Pierro J et al. Comparative effectiveness of 10 antiepileptic drugs in older adults witj epilepsy. Arch Neurol 2010;67:408-415
19. Waterhouse E, Towne A. Seizures in the elderly: Nuances in presentation and treatment. Cleve Clin J Med 2005;72(suppl 3):S26-S37
20. Johans SJ, Garst JR, Burkett DJ, Grahnke K, Martin B, Ibrahim TFm Anderson DE, Prabhu VC. Identification of preoperative and intraoperative risk factors for complications in the elderly undergoing elective craniotomy. World Neurosurgery 2017;107:216-225
21. Laigle-Donadey F, Sanson M. Pattern of care of high-grade gliomas. Rev Prat 2006;56:1779-1786
22. Chaichana KL, Garzon_Muvdi T, Parker S et al. Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol 2011;18:239-245
23. D’Amico RS, Cloney MB, Sonabend AM, Zacharia B, Nazarian MN, Iwamoto FM, Sisti MB, Bruce JN, McKhann GM. The safety of surgery in elderly patients with primary and recurrent glioblastoma. World Neurosurgery 2015;84(4):913-919
24. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 1994;12:627-42
25. Stupp R, Mason WP, van den Bert MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996
26. Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol. 2004;22(9):1583-1588
27. Perez-Larraya, Ducray F, Chinot O, Thomas IC, Taillandier L, Guillamo JS et al. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. Journal of Clınıcal Oncology 2011;29(22):3050-3055
28. Holdhoff M, Chamberlain MC. Controversies in the treatment of elderly patients with newly diagnosed glioblastoma. J Natl Compr Canc Netw. 2013;11(9):1165-1173
29. Kono M, Arakawa Y, Mineharu Y, Ohka F, Kinoshita M, Nakae S, Miyashita K, Luchi T, Hirose Y, Natsume A. et al. P09.50 Phase I tial of temozolomide plus bevacizumab for newly diagnosed high-grade gliomas in the elderly: Interim report. Neuro-Oncology 2017;19(3):81
30. Malmstrom A, Gronberg BH, Marosi C, et al. Temozolomide versus standart 6-week radiotherapy versus hypofractioned radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomized, phase 3 trial. Lancet Oncol. 2012;13(9):916-926
31. Wick W, Platten M, Meisner C, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 2012;13(7):707-715
32. Minniti G, Lanzetta G, Scaringi C, Caporello P, Salvati M, Arcella A, et al. Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys. 2012;83(1):93-9
33. Perez-Larraya JG, Delattre JY. Treating glioblastoma in the elderly. CNS Oncol 2012;1:193-201
34. Gehring K, Patwardhan SY, Collins R et al. A randomized trial on the efficacy of mthylphenidate and modafinil for improving cognitive functioning and symptoms in patients with primary brain tumor. J Neurooncol 2012;107:165-174
35. Cloney M, D’Amico R, Lebovic J, Nazarian M, Zacharia BE, Sisti MB, Bruce JN, McKhann GM, Iwamoto FM, Sonabend AM. Frailty in geriatric glioblastoma patients: a predictor of operative morbidity and outcome. World Neurosurgery 2016;89:362-367
36. Decoster L, Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 2015;26(2):288-300
37. Pallis AG, Fortpied C, Wedding U, et al. EORTC elderly task force position paper: Approach to the older cancer patient. Eur J Cancer 2010;46(9):1502-1513

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Derleme

Yazarlar

Nilgün Şenol ^*
Süleyman Demirel Üniversitesi, Tıp Fakültesi, Beyin ve Sinir Cerrahisi Anabilim Dalı
Türkiye

Hakan Murat Göksel
Süleyman Demirel Üniversitesi, Tıp Fakültesi, Beyin ve Sinir Cerrahisi Anabilim Dalı

Yayımlanma Tarihi

1 Eylül 2018

Gönderilme Tarihi

28 Kasım 2017

Kabul Tarihi

19 Aralık 2017

Yayımlandığı Sayı

Yıl 2018 Cilt: 25 Sayı: 3

DOI

https://doi.org/10.17343/sdutfd.358631

IZ

https://izlik.org/JA99DR87WC

Kaynak Göster

RIS / Bibtex

APA

Şenol, N., & Göksel, H. M. (2018). Geriatrik Hastalarda Nöroonkolojik Sorunlar. Medical Journal of Süleyman Demirel University, 25(3), 336-341. https://doi.org/10.17343/sdutfd.358631

AMA

1.Şenol N, Göksel HM. Geriatrik Hastalarda Nöroonkolojik Sorunlar. SDÜ Tıp Fak Derg. 2018;25(3):336-341. doi:10.17343/sdutfd.358631

Chicago

Şenol, Nilgün, ve Hakan Murat Göksel. 2018. “Geriatrik Hastalarda Nöroonkolojik Sorunlar”. Medical Journal of Süleyman Demirel University 25 (3): 336-41. https://doi.org/10.17343/sdutfd.358631.

EndNote

Şenol N, Göksel HM (01 Eylül 2018) Geriatrik Hastalarda Nöroonkolojik Sorunlar. Medical Journal of Süleyman Demirel University 25 3 336–341.

IEEE

[1]N. Şenol ve H. M. Göksel, “Geriatrik Hastalarda Nöroonkolojik Sorunlar”, SDÜ Tıp Fak Derg, c. 25, sy 3, ss. 336–341, Eyl. 2018, doi: 10.17343/sdutfd.358631.

ISNAD

Şenol, Nilgün - Göksel, Hakan Murat. “Geriatrik Hastalarda Nöroonkolojik Sorunlar”. Medical Journal of Süleyman Demirel University 25/3 (01 Eylül 2018): 336-341. https://doi.org/10.17343/sdutfd.358631.

JAMA

1.Şenol N, Göksel HM. Geriatrik Hastalarda Nöroonkolojik Sorunlar. SDÜ Tıp Fak Derg. 2018;25:336–341.

MLA

Şenol, Nilgün, ve Hakan Murat Göksel. “Geriatrik Hastalarda Nöroonkolojik Sorunlar”. Medical Journal of Süleyman Demirel University, c. 25, sy 3, Eylül 2018, ss. 336-41, doi:10.17343/sdutfd.358631.

Vancouver

1.Nilgün Şenol, Hakan Murat Göksel. Geriatrik Hastalarda Nöroonkolojik Sorunlar. SDÜ Tıp Fak Derg. 01 Eylül 2018;25(3):336-41. doi:10.17343/sdutfd.358631